15 research outputs found

    Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs

    Get PDF
    Objectives The protozoan parasite Giardia lamblia causes the intestinal disease giardiasis, which may lead to acute and chronic diarrhoea in humans and various animal species. For treatment of this disease, several drugs such as the benzimidazole albendazole, the nitroimidazole metronidazole and the nitrothiazolide nitazoxanide are currently in use. Previously, a G. lamblia nitroreductase 1 (GlNR1) was identified as a nitazoxanide-binding protein. The aim of the present project was to elucidate the role of this enzyme in the mode of action of the nitro drugs nitazoxanide and metronidazole. Methods Recombinant GlNR1 was overexpressed in both G. lamblia and Escherichia coli (strain BL21). The susceptibility of the transfected bacterial and giardial cell lines to nitazoxanide and metronidazole was analysed. Results G. lamblia trophozoites overexpressing GlNR1 had a higher susceptibility to both nitro drugs. E. coli were fully resistant to nitazoxanide under both aerobic and semi-aerobic growth conditions. When grown semi-aerobically, bacteria overexpressing GlNR1 became susceptible to nitazoxanide. Conclusions These findings suggest that GlNR1 activates nitro drugs via reduction yielding a cytotoxic produc

    Stable expression of Escherichia coli β-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing

    Get PDF
    Objectives In order to create a suitable model for high-throughput drug screening, a Giardia lamblia WB C6 strain expressing Escherichia coli glucuronidase A (GusA) was created and tested with respect to susceptibility to the anti-giardial drugs nitazoxanide and metronidazole. Methods GusA, a well-established reporter gene in other systems, was cloned into the vector pPacVInteg allowing stable expression in G. lamblia under control of the promoter from the glutamate dehydrogenase (gdh) gene. The resulting transgenic strain was compared with the wild-type strain in a vitality assay, characterized with respect to susceptibility to nitazoxanide, metronidazole and—as assessed in a 96-well plate format—to a panel of 15 other compounds to be tested for anti-giardial activity. Results GusA was stably expressed in G. lamblia. Using a simple glucuronidase assay protocol, drug efficacy tests yielded results similar to those from cell counting. Conclusions G. lamblia WB C6 GusA is a suitable tool for high-throughput anti-giardial drug screenin

    Hemocyanin conformational changes associated with SDS-induced phenol oxidase activation

    Get PDF
    The enzymatic activity of phenoloxidase is assayed routinely in the presence of SDS. Similar assay conditions elicit phenoloxidase activity in another type 3 copper protein, namely hemocyanin, which normally functions as an oxygen carrier. The nature of the conformational changes induced in type 3 copper proteins by the denaturant SDS is unknown. This comparative study demonstrates that arthropod hemocyanins can be converted from being an oxygen carrier to a form which exhibits phenoloxidase activity by incubation with SDS, with accompanying changes in secondary and tertiary structure. Structural characterisation, using various biophysical methods, suggests that the micellar form of SDS is required to induce optimal conformational transitions in the protein which may result in opening a channel to the di-copper centre allowing bulky phenolic substrates access to the catalytic site

    Aktivierung von Hämocyanin zur Tyrosinase

    No full text
    Ziel der Arbeit war die enzymatische Aktivierung von Cheliceraten-Hämocyanin zur Erforschung ihrer Phenoloxidase-Aktivität. Hierzu wurden zwei Hämocyanine in vergleichenden Untersuchungen herangezogen: Das bekannte 24-mer aus der Spinne Eurypelma californicum und das ebenfalls 24-mere Hämocyanin des Skorpions Pandinus imperator, dessen Struktur hier aufgeklärt wurde. Elektronenmikroskopisch und in der dynamischer Lichtstreuung sind sich beide Hämocyanine sehr ähnlich und sedimentieren bei analytischer Ultrazentrifugation ebenfalls in gleicher Weise (Sedimentationskoeffizient von 37 S (S20, W)). Durch Dissoziation im alkalischen Milieu gewinnt man bis zu zwölf Untereinheiten, von denen sich neun immunologisch unterscheiden lassen. Das absorptionsspektroskopische Verhalten von P. imperator- und E. californicum-Hämocyanin sowie Sekundärstrukturanalyse mittels CD-Spektroskopie ist nahezu identisch. Die Stabilität des Hämocyanins gegenüber Temperatur und Denaturierungsmitteln wurde mit Circulardichroismus- und Fluoreszenzspektroskopie sowie durch die enzymatische Aktivität untersucht. Erstmals konnten die Hämocyanine von P. imperator und E. californicum nicht nur zu einer stabilen Diphenoloxidase umgewandelt werden, sondern auch eine Monophenolhydroxylase-Aktivität induziert und reguliert werden. Für letztere Aktivität ist dabei die Präsenz von Tris- oder Hepes-Puffer wesentlich. Während sich die Monophenolhydroxylase-Aktivität nur auf Ebene der oligomeren Zustände beobachten lässt, erkennt man bei den isolierten Untereinheiten-Typen lediglich eine Diphenoloxidase-Aktivität. Bei dem Spinnen-Hämocyanin zeigen die Untereinheiten bc die stärkste katalytische Aktivität auf, bei P. imperator-Hämocyanin findet man drei bis vier Untereinheiten, die enzymatisch aktiv sind. Die Aktivierung mit SDS liefert den Hinweis, dass die Quartärstruktur in eine andere Konformation gebracht und nicht durch SDS denaturiert wird. Zugabe von Mg2+ reguliert die Phenoloxidase-Aktivität und verschiebt bei P. imperator-Hämocyanin die enzymatische Aktivität zugunsten der Diphenoloxidase. Mit keiner der zur Verfügung stehenden Methoden konnte jedoch ein Konformationsübergang eindeutig nachgewiesen werden. Die Stabilität scheint durch die niedrigen SDS-Konzentrationen nicht beeinträchtigt zu werden. Die sehr lange “Verzögerungsphase“ bei der Monophenolhydroxylase-Aktivität konnte durch Zugabe von katalytischem Diphenol drastisch verkürzt werden, was ein Hinweis auf die echte Tyrosinase-Aktivität des aktivierten Hämocyanins ist. Ein in vivo-Aktivator konnte bis jetzt noch nicht gefunden werden. Trotzdem scheinen die Hämocyanine in der Immunologie von Cheliceraten eine bedeutende Rolle zu spielen, indem sie die Rolle der Tyrosinasen / Phenoloxidasen beziehungsweise Catecholoxidasen übernehmen, die bei Cheliceraten nicht vorkommen. Weitere Möglichkeiten des Cheliceraten-Immunsystems, eindringende Fremdorganismen abzuwehren, wurden untersucht. Das Fehlen einer ´echten` Phenoloxidase-Aktivität bei den Cheliceraten, mit der Fähigkeit, sowohl mono- als auch diphenolische Substrate umzusetzen, stützt die Hypothese, dass aktiviertes Hämocyanin in vivo an die Stelle der Phenoloxidase tritt.Aim of this study was the enzymatic activation of chelicerate hemocyanin and the exploration of their phenol oxidase activity. Two hemocyanins were consulted in comparative studies: The well-known 24-meric hemocyanin of the tarantula Eurypelma californicum and the likewise 24-meric hemocyanin of the scorpion Pandinus imperator. The structure of the latter was elucidated. Concerning electron microscopy and dynamic light scattering, both hemocyanins are quite similar. They sediment in similar manner in the analytical ultracentrifuge (sedimentation coefficient 37 S (S20, W)). Dissociation in alkaline medium leads up to twelve subunits, nine of them are immunological distinguishable. Absorption spectroscopy and secondary structure analysis yield to similar results. The stability of the hemocyanin against temperature and denaturing agents was examined with circular dichroism spectroscopy and fluorescence spectroscopy as well as by checking the enzymatic activity. For the first time the hemocyanins of E. californicum and P. imperator could not only be converted to a stable diphenol oxidase, but also a monophenol hydroxylase activity could be induced and regulated. For the latter the presence of Tris or Hepes is essential. While monophenol hydroxylase activity can only be observed on the level of oligomeric hemocyanin, the isolated subunits display only diphenol oxidase activity. In the spider hemocyanin the subunits bc have the strongest enzymatic activity. In the scorpion hemocyanin three to four subunits are enzymatically active. The activation with SDS delivers the indication that the quaternary structure is turned into a different conformation, and that no denaturing by SDS occurs. Addition of Mg2+ regulates the phenol oxidase activity and adjusts the enzymatic activity of P. imperator hemocyanin in favour of the diphenol oxidase. However, with no available method a conformational change could be definitely verified. The protein stability doesn’t seem to be altered by the low SDS concentration. The very long “lag phase” of the monophenol hydroxylase activity could be drastically decreased by catalytic amounts of diphenol. This is a hint towards the ´real` tyrosinase activity of the activated hemocyanin. Until now, an in vivo activator could not yet been found. Nevertheless, the hemocyanins seem to play a crucial role in the immunity of chelicerates. They take over the role of tyrosinases / phenol oxidases respectively catecholoxidases / diphenol oxidases, which do not exist in chelicerates. Further possibilities of the chelicerate immune system to fend off penetrating foreign organisms were examined. The lack of a ´real` tyrosinase activity in chelicerates and the ability to convert both monophenolic and diphenolic substrates supports the hypothesis that activated hemocyanin takes over the place of phenol oxidase in vivo

    Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs

    Get PDF
    OBJECTIVES: The protozoan parasite Giardia lamblia causes the intestinal disease giardiasis, which may lead to acute and chronic diarrhoea in humans and various animal species. For treatment of this disease, several drugs such as the benzimidazole albendazole, the nitroimidazole metronidazole and the nitrothiazolide nitazoxanide are currently in use. Previously, a G. lamblia nitroreductase 1 (GlNR1) was identified as a nitazoxanide-binding protein. The aim of the present project was to elucidate the role of this enzyme in the mode of action of the nitro drugs nitazoxanide and metronidazole. METHODS: Recombinant GlNR1 was overexpressed in both G. lamblia and Escherichia coli (strain BL21). The susceptibility of the transfected bacterial and giardial cell lines to nitazoxanide and metronidazole was analysed. RESULTS: G. lamblia trophozoites overexpressing GlNR1 had a higher susceptibility to both nitro drugs. E. coli were fully resistant to nitazoxanide under both aerobic and semi-aerobic growth conditions. When grown semi-aerobically, bacteria overexpressing GlNR1 became susceptible to nitazoxanide. CONCLUSIONS: These findings suggest that GlNR1 activates nitro drugs via reduction yielding a cytotoxic product

    Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: The Long-Term Care Facility Study.

    No full text
    BACKGROUND:Multiresistant organisms pose a threat for patients and care recipients. Control interventions need to be tailored to region, the type of institution considered, and risk factors. The German state of Saarland is ideally suited to study colonisation epidemiology throughout its various health and care institutions. After conclusion of a large admission prevalence study in acute care hospitals, we now performed a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence study in Saarland long term care facilities (LTCF), allowing for a direct comparison with respect of MRSA prevalence and associated risk factors between these two institutional types located within a confined region. METHODOLOGY AND PRINCIPAL FINDINGS:Of all LTCF of the region, 65/136 participated in the study performed between 09/2013 and 07/2014. Overall, complete microbiological specimen and questionnaires of 2,858 of 4,275 (66.8%) LTCF residents were obtained. 136/2,858 (4.8%) screened residents revealed MRSA carrier status. Multivariate risk factor analysis yielded ulcer/deep soft tissue infection, urinary tract catheter, and MRSA history with multiple MRSA decolonisation cycles to be independently associated with MRSA carrier status. CONCLUSION:As already known from previous studies, colonisation with MRSA is common in LTCF residents even in an area with relatively low MRSA prevalence. This found prevalence can now be related to the acute care admission prevalence (2.2%) as well as to the admission prevalence in acute care geriatric departments (7.6%). The common clonal attribution (spa type) of MRSA isolates prevalent in the LTCF population as well as in the acute care admission population points towards a close relationship between both types of institutions. However, the ostensible absence of risk factors such as "previous hospitalisation" in conjunction with newly identified factors such as "multiple decolonisation cycles" refers to MRSA colonisation risks independent of contact with acute care facilities. Overall, this large LTCF point prevalence study allows data-based, region-tailored decisions on MRSA screening policies and provides a basis for additional preventative measures
    corecore